Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

5 months ago 18
Read Entire Article
  1. Homepage
  2. Finance
  3. Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

Related

Malaysia denies ex-PM Najib’s house arrest bid ahead of key 1MDB verdict

Malaysia denies ex-PM Najib’s house arrest bid ahead of key ...

25 minutes ago 0
Uber partners with Baidu to start robotaxi tests in the UK- Bloomberg

Uber partners with Baidu to start robotaxi tests in the UK- ...

25 minutes ago 0
Japan eyes $7 trillion household savings pile for fresh bond demand

Japan eyes $7 trillion household savings pile for fresh bond...

25 minutes ago 0

Trending

1. latto
2. car accident attorney
3. benicio del toro
4. heated rivalry cast
5. harry potter movies
6. christopher nolan
7. daniel radcliffe
8. charlie sheen
9. weather los angeles
10. dennis schroder

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 638
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 512
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 374
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 331
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 328
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved